People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotech / Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Galatea Bio, Inc. | — | Biotech / Pharma | Seed | $3.7M | $16.2M | 2024 |
Nicholas D. Katsanis at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Nicholas D. Katsanis on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Carlos D. Bustamante | 1 | 1 |
| Muzammil D. Mansuri | 1 | 1 |
| Arthur D. Polk | 1 | 1 |
| Wale D. Ayeni | 1 | 1 |
| Cindy D. Cheung | 1 | 1 |
| Alexander D. Ioannidis | 1 | 1 |
| Mohit D. Kaushal | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.